[ Price : $8.95]
A Phase 3 clinical trial evaluating Alexions anselamimab for light chain amyloidosis fails to meet its primary endpoint, but shows...[ Price : $8.95]
FDA releases a funding opportunity for natural history studies to advance product development in rare diseases and conditions.[ Price : $8.95]
FDA releases the form FDA-483 with seven observations from an inspection at Indias Natco Pharma.[ Price : $8.95]
FDA publishes a draft guidance on characterizing the effects of some oncology drugs when used in combination with other drugs.[ Price : $8.95]
FDA grants Zenith Epigenetics a fast-track designation for its ZEN-3694 and its use for treating metastatic or unresectable NUT ca...[ Price : $8.95]
FDA medical reviewers question the demonstration of efficacy in an Otsuka NDA for a combination of Rexulti and Zoloft to treat PTS...[ Price : $8.95]
FDA lifts a partial clinical hold against Kezar Life Sciences and its completed PORTOLA Phase 2a clinical trial evaluating zetomip...[ Price : $8.95]
FDA clears a Caranx Medical 510(k) for its TaviPilot Soft, which the company describes as AI software for real-time intra-operativ...